Brief: Kala Pharmaceuticals Reports Q1 2023 Financial Results And Provides Corporate Update

KALA BIO

09/05/2023 13:44

May 9 (Reuters) - Kala Pharmaceuticals Inc  KALA.O :
    * KALA PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * KALA PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE $6.99

Source text for Eikon:  ID:nGNX9NMPfj 
Further company coverage:  KALA.O 

 ((Reuters.Briefs@thomsonreuters.com;))